BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37974396)

  • 1. Assessing the impact of discordant antibiotic treatment on adverse outcomes in community-onset UTI: a retrospective cohort study.
    Aryee A; Rockenschaub P; Robson J; Ahmed Z; Nic Fhogartaigh C; Ball D; Hayward A; Shallcross L
    J Antimicrob Chemother; 2024 Jan; 79(1):134-142. PubMed ID: 37974396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital admission after primary care consultation for community-onset lower urinary tract infection: a cohort study of risks and predictors using linked data.
    Aryee A; Rockenschaub P; Robson J; Priebe M; Ahmed Z; Fhogartaigh CN; Ball D; Hayward A; Shallcross L
    Br J Gen Pract; 2023 Sep; 73(734):e694-e701. PubMed ID: 37487642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
    Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
    Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of adverse outcomes following urinary tract infection in older people with renal impairment: Retrospective cohort study using linked health record data.
    Ahmed H; Farewell D; Francis NA; Paranjothy S; Butler CC
    PLoS Med; 2018 Sep; 15(9):e1002652. PubMed ID: 30199555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic prescribing for lower UTI in elderly patients in primary care and risk of bloodstream infection: A cohort study using electronic health records in England.
    Shallcross L; Rockenschaub P; Blackburn R; Nazareth I; Freemantle N; Hayward A
    PLoS Med; 2020 Sep; 17(9):e1003336. PubMed ID: 32956399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of antibiotic treatment duration on outcomes in older men with suspected urinary tract infection: Retrospective cohort study.
    Ahmed H; Farewell D; Francis NA; Paranjothy S; Butler CC
    Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):857-866. PubMed ID: 31050078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third-Generation Cephalosporin Resistance and Associated Discordant Antibiotic Treatment in Emergency Department Febrile Urinary Tract Infections.
    Mark DG; Hung YY; Salim Z; Tarlton NJ; Torres E; Frazee BW
    Ann Emerg Med; 2021 Sep; 78(3):357-369. PubMed ID: 33781606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of urine testing in outpatients treated for urinary tract infection.
    Copp HL; Yiee JH; Smith A; Hanley J; Saigal CS;
    Pediatrics; 2013 Sep; 132(3):437-44. PubMed ID: 23918886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study.
    Gharbi M; Drysdale JH; Lishman H; Goudie R; Molokhia M; Johnson AP; Holmes AH; Aylin P
    BMJ; 2019 Feb; 364():l525. PubMed ID: 30814048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and Outcomes in Children with Third-Generation Cephalosporin-Resistant Urinary Tract Infections.
    Wang ME; Greenhow TL; Lee V; Beck J; Bendel-Stenzel M; Hames N; McDaniel CE; King EE; Sherry W; Parmar D; Patrizi ST; Srinivas N; Schroeder AR
    J Pediatric Infect Dis Soc; 2021 May; 10(5):650-658. PubMed ID: 33595081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study.
    Anesi JA; Lautenbach E; Nachamkin I; Garrigan C; Bilker WB; Omorogbe J; Dankwa L; Wheeler M; Tolomeo P; Han JH;
    BMC Infect Dis; 2019 Feb; 19(1):163. PubMed ID: 30764770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort and qualitative study.
    Little P; Turner S; Rumsby K; Warner G; Moore M; Lowes JA; Smith H; Hawke C; Turner D; Leydon GM; Arscott A; Mullee M
    Health Technol Assess; 2009 Mar; 13(19):iii-iv, ix-xi, 1-73. PubMed ID: 19364448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-onset healthcare-related urinary tract infections: comparison with community and hospital-acquired urinary tract infections.
    Aguilar-Duran S; Horcajada JP; Sorlí L; Montero M; Salvadó M; Grau S; Gómez J; Knobel H
    J Infect; 2012 May; 64(5):478-83. PubMed ID: 22285591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National trends in the treatment of urinary tract infections among Veterans' Affairs Community Living Center residents.
    Appaneal HJ; Caffrey AR; Lopes VV; Crnich CJ; Dosa DM; LaPlante KL
    Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1087-1093. PubMed ID: 31354115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, etiology and antibiotic resistance patterns of community-acquired urinary tract infections in Dhaka, Bangladesh.
    Islam MA; Islam MR; Khan R; Amin MB; Rahman M; Hossain MI; Ahmed D; Asaduzzaman M; Riley LW
    PLoS One; 2022; 17(9):e0274423. PubMed ID: 36107878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent Urinary Tract Infection in Adult Patients, Risk Factors, and Efficacy of Low Dose Prophylactic Antibiotics Therapy.
    Alghoraibi H; Asidan A; Aljawaied R; Almukhayzim R; Alsaydan A; Alamer E; Baharoon W; Masuadi E; Al Shukairi A; Layqah L; Baharoon S
    J Epidemiol Glob Health; 2023 Jun; 13(2):200-211. PubMed ID: 37273158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective review of ceftriaxone versus levofloxacin for treatment of E. coli urinary tract infections.
    Wang SS; Ratliff PD; Judd WR
    Int J Clin Pharm; 2018 Feb; 40(1):143-149. PubMed ID: 29147962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between clinical outcomes and empirical antibiotic therapy in patients with community-onset Gram-negative bloodstream infections: a cohort study from a large teaching hospital.
    Aryee A; Rockenschaub P; Gill MJ; Hayward A; Shallcross L
    Epidemiol Infect; 2020 Sep; 148():e225. PubMed ID: 32912362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term antibiotics for preventing recurrent urinary tract infection in children.
    Williams G; Craig JC
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD001534. PubMed ID: 30932167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.